Millennium Trust and ByAllAccounts Collaborating on New

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Millennium Trust and ByAllAccounts Collaborating on New Automated Delivery Solution for Alternative Asset Valuations

OAK BROOK, IL--(Marketwired - Jun 28, 2013) -   Millennium Trust Company , the leading alternative asset custodian for Advisors, and ByAllAccounts , the sole provider of intelligent data aggregation for financial services companies, today announced they are collaborating on a new automated solution for reporting alternative asset values. The platform will automate data collection and aggregation of valuations for alternative investments and will deliver data directly into an Advisor's portfolio management system. The collaboration, a first of its kind, starts to bridge the gap between the automated data collection and reporting process for traditional investments and today's manual and unstructured process for alternative investments. 

Advisors want to run their operations as efficiently as possible. The current method, however, of manually inputting data from multiple alternative assets, such as REITS, hedge funds and private equity funds, is inefficient and costly. As more family offices and advisory firms add alternative investments to clients' portfolios, it is imperative that a solution is built to provide consolidated and timely reporting on these illiquid and often hard-to-value assets. The new solution will address the need of many Advisors whose back-office teams spend many hours manually inputting data from multiple sources, and will free them to focus on more productive activities such as servicing their clients. Investment sponsors will also benefit as their data is gathered electronically, which can result in timelier processing of updated valuations.

In creating its new service, ByAllAccounts' will draw upon its patented expertise in data aggregation from more than 4,000 data sources and Millennium Trust's in-depth knowledge of alternative assets and access to more than 8,000 investment sponsors. The solution will consist of a platform for the automated delivery of alternative investment valuations data to the Millennium Trust advisor platform as well as to other ByAllAccounts clients. ByAllAccounts will aggregate, enrich and deliver this data via direct feeds, expanding its current network of alternative investment connections that is available to current clients.

"Having spent more than a decade in the alternative asset custody business, one of the major challenges we regularly face is the amount of manpower spent to obtain, record, review and reconcile the data. This tool will streamline the process, improve efficiencies and result in a better experience for our clients," states T. Scott McCartan, CEO of Millennium Trust.

"ByAllAccounts specializes in aggregation and delivery of marketable as well as non-marketable financial account data, such as hedge fund, REIT, private equity, 401(k) and 529 accounts," said ByAllAccounts CEO James Carney. "Together with Millennium Trust, we look forward to being the first to automate delivery of alternative investment data into industry leading platforms in the wealth management industry and in doing so eliminating time-consuming and costly manual data entry of limited partner interests."

The first phase of the solution is expected to be completed for rollout within six months.

About Millennium Trust Company Millennium Trust Company is a leading financial services firm offering niche alternative custody solutions to institutions, advisors and individuals. We serve as a complement to services offered by other custodians. Our innovative solutions include alternative asset custody , rollover solutions , private fund custody and advisor support services . Additional information about Millennium Trust Company may be found at www.mtrustcompany.com . Millennium Trust performs the duties of a custodian and, as such, does not provide investment advice or sell investments, nor offer any tax or legal advice.

About ByAllAccounts

ByAllAccounts is the only provider of intelligent data aggregation for financial services companies and the platforms on which their businesses depend. Their patented, intelligent data aggregation system implements a knowledge-based process that uses artificial intelligence to gather and transform financial account data and deliver it to portfolio management, reconciliation, compliance, trust accounting and performance systems.

The financial industry's most reputable advisory firms , financial institutions, and financial technology vendors rely on ByAllAccounts as their primary connector to structured and unstructured financial account data , enabling them to streamline their third-party relationships and to empower their applications and services. For more information, visit www.byallaccounts.com .

Millennium Trust and ByAllAccounts are responsible solely for reporting asset values provided by investment sponsors; they do not calculate the actual value of an alternative asset.

Contact Information Mary Hackbarth SVP, Director of Marketing Millennium Trust Company 630.368.5642 mhackbarth@mtrustcompany.com Cynthia Stephens Vice President ByAllAccounts 781.376.0801 x130 cstephens@byallaccounts.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading